We are seeking volunteers to participate in a clinical study entitled “PALPEBRAL”, starting on January 27, 2026, at ALYATEC.
Participation is compensated and will help evaluate the effectiveness of the dermocosmetic product Palpebral Balm in reducing symptoms of mild to moderate atopic dermatitis on the face and neck. The balm is developed by Laboratoires SVR and is commercially available. It is a moisturizing, soothing, repairing, and protective skincare product with a triple action: anti-itching, anti-irritation, and protection against external aggressors.
Depending on the volunteers’ profile (use of a topical corticosteroid treatment or not), participation will last 4 weeks (3 visits) or 8 weeks (4 visits). All visits take place at ALYATEC’s premises in Strasbourg and last no more than one hour. Clinical and medical assessments will be carried out during these visits, and the product must be used daily throughout the study period.
The study is intended for adults experiencing eczema flare-ups on the face and neck (whether treated or not with topical corticosteroids).
Compensation of €40 per visit is offered to cover the time and constraints of the study. Total compensation will therefore range between €120 and €160. Travel expenses may be reimbursed upon presentation of receipts.
If you are interested in taking part in the PALPEBRAL study or would like additional information, please contact us.
Palpebral
Palpebral
